Ferrer Montiel, Antonio Vicente
 Distribuzione geografica
Continente #
NA - Nord America 134
EU - Europa 133
AS - Asia 39
Totale 306
Nazione #
US - Stati Uniti d'America 132
IE - Irlanda 38
IT - Italia 35
DE - Germania 20
SE - Svezia 16
CN - Cina 12
UA - Ucraina 10
HK - Hong Kong 8
IN - India 7
BE - Belgio 6
SG - Singapore 6
TR - Turchia 4
CA - Canada 2
GB - Regno Unito 2
IR - Iran 2
AT - Austria 1
CZ - Repubblica Ceca 1
FI - Finlandia 1
FR - Francia 1
LV - Lettonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 306
Città #
Dublin 38
Ann Arbor 23
Jacksonville 22
Piemonte 14
Chandler 11
Hong Kong 8
Beijing 6
Brussels 6
Dearborn 5
Bremen 4
Lawrence 4
Novara 4
Princeton 4
Ashburn 3
Dallas 3
Kocaeli 3
Milan 3
Nonantola 3
Wilmington 3
Imola 2
Munich 2
New York 2
San Mateo 2
Toronto 2
Andover 1
Bratislava 1
Brno 1
Cambridge 1
Chengdu 1
Como 1
Falkenstein 1
Guangzhou 1
Hefei 1
Helsinki 1
Mülheim 1
Nanchang 1
Rho 1
Riga 1
Saarbrücken 1
Sacramento 1
Santa Clara 1
Shanghai 1
Singapore 1
Strasbourg 1
Turin 1
Vienna 1
Zanjan 1
Totale 200
Nome #
Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders 90
Contribution of hyperpolarizing ion channels to acute cold hypersensitivity induced by oxaliplatin administration 80
TRPV1 Modulator Compounds 70
Early Stimulation of TREK Channel Transcription and Activity Induced by Oxaliplatin-Dependent Cytosolic Acidification 58
First-in-Class Dual Hybrid Carbonic Anhydrase Inhibitors and Transient Receptor Potential Vanilloid 1 Agonists Revert Oxaliplatin-Induced Neuropathy 16
Totale 314
Categoria #
all - tutte 1.435
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.435


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202037 0 0 0 0 1 6 14 0 4 8 4 0
2020/202161 6 4 3 6 10 6 6 0 6 10 4 0
2021/202239 3 4 3 8 1 1 1 0 1 5 5 7
2022/2023107 8 5 7 3 12 9 7 4 42 2 7 1
2023/202437 3 4 7 2 4 0 10 0 0 0 2 5
2024/202513 3 2 6 1 1 0 0 0 0 0 0 0
Totale 314